Recent advances in vasodilator therapy. Part I: physiologic correlations
Aranda, J.M.; Linares, E.; Hernández-López, E.; Cintrón, G.; Song, S.
Boletin de la Asociacion Medica de Puerto Rico 73(1): 3-10
1981
ISSN/ISBN: 0004-4849 PMID: 7020713 Document Number: 701346
Document emailed within 1 workday
Related Documents
Hager, W.D. 1977: Vasodilator therapy in coronary artery disease. Part IIi Arizona Medicine 34(8): 565-567Dabizzi, R.P.; Fantini, F.; Cappelli, G.; Grandonico, F. 1970: Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs Minerva Cardioangiologica 18(5): 287-290
Thomashow, D.; Summer, W.R.; Soin, J.; Wagner, H.N.; Brown, T.C. 1977: Lung disease in reformed drug addicts: diagnostic and physiologic correlations Johns Hopkins Medical Journal 141(1): 1-8
Kratochvílovà, B.; Profant, O.; Astl, J.ír.; Holý, R. 2016: Our experience in the treatment of idiopathic sensorineural hearing loss (ISNHL): Effect of combination therapy with HBO₂ and vasodilator infusion therapy Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 43(7): 771-780
Schwartze, H. 1970: Use of vectorcardiography as a research method in physiologic development. II. Correlations between the development of the heart and the spatial vectorcardiogram during postnatal ontogenesis in the guinea pig Acta Biologica et Medica Germanica 24(3): 313-325
Velican, D.; Iacob, M. 1989: Anatomoclinical correlations in coronary heart disease: recent advances and unanswered questions Medecine Interne 27(1): 3-14
Wyszyńska, T. 1975: Refractoriness to therapy in nephrotic syndrome in children. Part II. Clinico-morphological correlations in corticosteroid-resistant nephrotic syndrome in children Pediatria Polska 50(1): 9-18
Sasayama, S. 1981: Afterload reduction and vasodilator therapy Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 78(3): 127-137
Verin, P. 1970: Vasodilator therapy and ocular diseases Bordeaux Medical 3(10): 2509-2510
Bower, P.J. 1982: Vasodilator therapy in congestive heart failure Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 134(2): 36-39
Mason, D.T.; Awan, N.A.; Demaria, A.N.; Lee, G.; Joye, J.A.; Amsterdam, E.A. 1979: Vasodilator therapy for chronic heart failure Comprehensive Therapy 5(7): 6-14
Just, H.; Drexler, H.; Holubarsch, C. 1988: Therapy of heart failure with vasodilator agents Zeitschrift für Kardiologie 77(Suppl 5): 97-101
Katila, M.; Luomanmäki, K. 1980: Vasodilator therapy in congestive heart failure Duodecim; Laaketieteellinen Aikakauskirja 96(5): 430-443
Ito, T.; Matsumoto, S.; Ito, Y. 1978: Chronic heart failure and vasodilator therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3565-3572
Class, J.J.; Bareiss, P.; Pasquali, J.L.; Meyer, R.; Weryha, A.; Storck, D.; Warter, J. 1978: Intravenous nitroglycerin as vasodilator therapy in acute myocardial infarction La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 54(29-32): 919-924
Williams, R.A.; Wilson, S.E. 1980: Radioxenon washout for evaluation of vasodilator therapy in mesenteric ischemia American Journal of Gastroenterology 73(5): 408-413
Groden, D.L. 1993: Vasodilator therapy for congestive heart failure. Lessons from mortality trials Archives of Internal Medicine 153(4): 445-454
Martin, D.L. 1984: New advances in therapeutic instruments. Part 2 Dimensions in Health Service 61(8): 38
Artese, D.; Albani, A.; Di Tomasso, E. 1983: Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution Minerva Medica 74(13): 715-722
Almahroos, M.; Kurban, A.K. 2004: Ultraviolet carcinogenesis in nonmelanoma skin cancer part II: review and update on epidemiologic correlations Skinmed 3(3): 132-139